Mrs PAWANA SHARMA
Research Fellow
work
+44 (0)1224 438091
work
fax
+44 (0)1224 554580
pref
p.sharma@abdn.ac.uk
pref
Health Services Research unit
University of Aberdeen
2nd Floor, Health Sciences Building
Foresterhill
Aberdeen
AB25, 2ZD
Research Fellow (Systematic Reviewer)
|
|
Personal Details
|
||||||||||
Jump to:
Biography
Pawana Sharma joined the Systematic Review Team within the Health Service Research Unit in October 2009 as a Research Fellow (Systematic Reviewer). She gained a degree of MSc in Public Health and Health Service Research in 2008 from the University of Aberdeen. She is a graduate pharmacist registered with Nepal Pharmacy Council with a first class honours degree in Bachelor of Pharmacy. Before joining the Unit, she used to work with Aberdeen Renal Research group working on a project funded by Health Technology Assessment (HTA), to assess the clinical and costeffectiveness of early referral of chronic kidney disease. She also worked with Aberdeen Technology Assessment Review team. She has now worked on various assessments including public health intervention, drug intervention and non-drug intervention. Currently she is involved in the Health Technology Assessment Reviews funded project activity.
^ top
Research Interests
Evidence synthesis
Management and care of chronic diseases
Physical activity and public health pharmacy
^ top
Current Research
Currently leading the clinical effectiveness part of the following reviews:
Systematic review of the diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy.
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: Systematic review and economic evaluation.(commissioned by the Diagnostic Assessment Programmes for National Institute for Health and Clinical Excellence(NICE))
^ top
Teaching Responsibilities
Supervision of MSc students (Public Health and Health Services Research; International Health and Health Services Research; Global Health).
Contribution in marking thesis and exam papers of MSc in Public Health and Health Services Research/International Health and Health Services Research/Global Health).
^ top
Published abstracts
Sharma P, Boyers D, Boachie C, Stewart F, Miedzybrodzka Z, Simpson W, Kilonzo M, McNamee P, Mowatt G: Elucigene and LIPOchip for FH:
NICE Diagnostic Assessment Review (DAR): invited presentation; Scotish lipids forum, dunkeld, November 2011
Sharma P, Black C, Scotland G, McCullough K, Robertson L, Fluck N, Macleod AM, McNamee P, Prescott G, WC Smith from ARRC HTA group, “ Approaches to care in Chronic Kidney Disease: supporting the development of a health economics model”.HTAi 2010- Maximizing the value of HTA, 8th June 2010, Dublin, published in abstract book.
Sharma P, Black C, Scotland G, McCullough K, Robertson L, Fluck N, Macleod AM, McNamee P, Prescott G, Smith WC from ARRC HTA group, “The building blocks for complex decision making: an example of HTA in chronic kidney disease care”. HTAi 2010-Maximizing the value of HTA, 8th June 2010, Dublin, published in abstract book.
Sharma P, Hislop J, Fraser C, Mowatt G, “ Inadequate reporting of dose information in drug trials: impact on systematic review workload and policy implications”. Health Technology Assessment International 2010- Maximizing the value of HTA, 8th June 2010, Dublin, published in abstract book.
Sharma P, McCullough K, Black C, “Natural history of early chronic kidney disease: a systematic review” Public Health 2008-Forging New Collaborations, 13th November 2008, Aviemore. Website http://conventions.nss.scot.nhs.uk/
^ top
Publications
Contributions to Journals
Articles
- McCullough, KA., Sharma, P., Ali, TZ., Khan, I., Smith, WCS., MacLeod, A. & Black, C. (in press). 'Measuring the Population Burden of Chronic Kidney Disease: A Systematic Literature Review of the estimated prevalence of impaired kidney function'. Nephrology Dialysis Transplantation.
- Sharma, P., Boyers, D., Boachie, C., Stewart, F., Miedzybrodzka, Z., Simpson, W., Kilonzo, M., McNamee, P. & Mowatt, G. (2012). 'Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation'. Health Technology Assessment, vol 16, no. 17, pp. 1-266.
[Online] DOI: 10.3310/hta16170
[Online] AURA: Sharma_2012.pdf - Hislop, J., Quayyum, Z., Elders, A., Fraser, C., Jenkinson, D., Mowatt, G., Sharma, P., Vale, L. & Petty, R. (2011). 'Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation'. Health Technology Assessment, vol 15, no. 25, pp. 1-178.
[Online] DOI: 10.3310/hta15250
[Online] AURA: Hislop_2011.pdf - Hislop, JM., Mowatt, G., Sharma, P., Fraser, CM., Elders, AS., Jenkinson, DJ., Vale, L. & Petty, RD. (in press). 'Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose'. Journal of Gastrointestinal CAncer.
[Online] DOI: 10.1007/s12029-011-9325-6 - Shyangdan, DS., Royle, PL., Clar, C., Sharma, P. & Waugh, NR. (2010). 'Glucagon-like peptide analogues for type 2 diabetes mellitus: Systematic review and meta-analysis'. BMC Endocrine Disorders, vol 10.
[Online] DOI: 10.1186/1472-6823-10-20 - Black, C., Sharma, P., Scotland, G., McCullough, K., McGurn, D., Robertson, L., Fluck, N., MacLeod, A., McNamee, P., Prescott, G. & Smith, C. (2010). 'Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis'. Health Technology Assessment, vol 14, no. 21, pp. 1-184.
[Online] DOI: 10.3310/hta14210 - Blackburn, R., Parke, C., Sharma, P., McCullough, KA. & Black, C. (2009). 'Angiotensin converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1-3) non-diabetic chronic kidney disease (protocol)'. Cochrane Database of Systematic Reviews.
Scientific Reviews
- Sharma, P., Blackburn, RC., Parke, CL., McCullough, K., Marks, A. & Black, C. (2011). 'Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease'. Cochrane Library, no. 10.
[Online] DOI: 10.1002/14651858.CD007751.pub2 - Sharma, P., McCullough, K., Scotland, G., McNamee, P., Prescott, G., Macleod, A., Fluck, N., Smith, WC. & Black, C. (2010). 'Does stage-3 chronic kidney disease matter? A systematic literature review'. British Journal of General Practice, vol 60, no. 575, pp. 442-448.
[Online] DOI: 10.3399/bjgp10X502173
^ top
‹ back